ShareHope Medicine Co Ltd (TWO:8403) — Market Cap & Net Worth
Market Cap & Net Worth: ShareHope Medicine Co Ltd (8403)
ShareHope Medicine Co Ltd (TWO:8403) has a market capitalization of $93.23 Million (NT$2.96 Billion) as of May 2, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #19447 globally and #1112 in its home market, demonstrating a -4.44% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ShareHope Medicine Co Ltd's stock price NT$21.50 by its total outstanding shares 137640341 (137.64 Million). Analyse 8403 cash generation efficiency to see how efficiently the company converts income to cash.
ShareHope Medicine Co Ltd Market Cap History: 2015 to 2026
ShareHope Medicine Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $132.01 Million to $93.23 Million (-1.91% CAGR).
ShareHope Medicine Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ShareHope Medicine Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.03x
ShareHope Medicine Co Ltd's market cap is 0.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.63x
ShareHope Medicine Co Ltd's market cap is 0.63 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $115.81 Million | $2.62 Billion | $124.37 Million | 0.04x | 0.93x |
| 2018 | $87.67 Million | $3.06 Billion | $145.85 Million | 0.03x | 0.60x |
| 2019 | $108.74 Million | $3.12 Billion | $195.05 Million | 0.03x | 0.56x |
| 2020 | $132.97 Million | $4.10 Billion | $247.71 Million | 0.03x | 0.54x |
| 2021 | $109.96 Million | $3.85 Billion | $232.66 Million | 0.03x | 0.47x |
| 2022 | $146.57 Million | $4.14 Billion | $293.95 Million | 0.04x | 0.50x |
| 2023 | $142.67 Million | $3.87 Billion | $124.56 Million | 0.04x | 1.15x |
| 2024 | $125.54 Million | $4.33 Billion | $200.10 Million | 0.03x | 0.63x |
Competitor Companies of 8403 by Market Capitalization
Companies near ShareHope Medicine Co Ltd in the global market cap rankings as of May 2, 2026.
Key companies related to ShareHope Medicine Co Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #246 globally with a market cap of $99.71 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #441 globally with a market cap of $59.14 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #570 globally with a market cap of $45.94 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1111 globally with a market cap of $22.95 Billion USD ( AU$32.44 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #246 | McKesson Corporation | NYSE:MCK | $99.71 Billion | $814.02 |
| #441 | Cencora Inc. | NYSE:COR | $59.14 Billion | $304.00 |
| #570 | Cardinal Health Inc | NYSE:CAH | $45.94 Billion | $195.24 |
| #1111 | Sigma Healthcare Ltd | AU:SIG | $22.95 Billion | AU$2.81 |
ShareHope Medicine Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, ShareHope Medicine Co Ltd's market cap moved from $132.01 Million to $ 93.23 Million, with a yearly change of -1.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$93.23 Million | -7.92% |
| 2025 | NT$101.26 Million | -19.34% |
| 2024 | NT$125.54 Million | -12.01% |
| 2023 | NT$142.67 Million | -2.66% |
| 2022 | NT$146.57 Million | +33.29% |
| 2021 | NT$109.96 Million | -17.30% |
| 2020 | NT$132.97 Million | +22.28% |
| 2019 | NT$108.74 Million | +24.03% |
| 2018 | NT$87.67 Million | -24.29% |
| 2017 | NT$115.81 Million | +13.31% |
| 2016 | NT$102.20 Million | -22.58% |
| 2015 | NT$132.01 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of ShareHope Medicine Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $93.23 Million USD |
| MoneyControl | $93.23 Million USD |
| MarketWatch | $93.23 Million USD |
| marketcap.company | $93.23 Million USD |
| Reuters | $93.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ShareHope Medicine Co Ltd
ShareHope Medicine Co., Ltd. provides integrated medical services in Taiwan. It is involved in the health management and operation activities; human resource dispatch of professional medical staff; provision of medical, pharmaceutical, and health devices, as well as long-distance health care services; and rental of medical devices. ShareHope Medicine Co., Ltd. was founded in 2003 and is based in … Read more